4th Annual CEO Remuneration Report – Wexford Hayes

31 January 2019

This 4th annual CEO Remuneration report reviews the remuneration of the top 100 public companies listed on the Australian Securities Exchange for the Health Care & Biotechnology Sector. The report provides insight into remuneration in the sector and is split into categories to enable meaningful comparison, due to the diversity and size of organisations in the sector.

For Australian market purposes we have only included Chief Executives Officers (including Managing Directors) based in Australia who are paid in Australian dollars.

CEO Remuneration Report FY18

Lee Rochester
Client Partner
Wexford Hayes
Email – lee.rochester@wexfordhayes.com


News & opinion

Member Directory